Veradigm Price to Free Cash Flow Ratio 2012-2022 | MDRX
Historical price to free cash flow ratio values for Veradigm (MDRX) since 2012.
| Veradigm Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-06-17 | 4.80 | 6.46 | |
| 2022-12-31 | 17.64 | $0.74 | 23.74 |
| 2022-09-30 | 15.23 | $0.95 | 15.96 |
| 2022-06-30 | 14.83 | $1.02 | 14.55 |
| 2022-03-31 | 22.52 | $-0.40 | 0.00 |
| 2021-12-31 | 18.45 | $-0.85 | 0.00 |
| 2021-09-30 | 13.37 | $-2.17 | 0.00 |
| 2021-06-30 | 18.51 | $-2.18 | 0.00 |
| 2021-03-31 | 15.02 | $-0.76 | 0.00 |
| 2020-12-31 | 14.44 | $-0.94 | 0.00 |
| 2020-09-30 | 8.14 | $-0.09 | 0.00 |
| 2020-06-30 | 6.77 | $-0.27 | 0.00 |
| 2020-03-31 | 7.04 | $-0.48 | 0.00 |
| 2019-12-31 | 9.82 | $-0.44 | 0.00 |
| 2019-09-30 | 10.98 | $-0.64 | 0.00 |
| 2019-06-30 | 11.63 | $-0.75 | 0.00 |
| 2019-03-31 | 9.54 | $-0.67 | 0.00 |
| 2018-12-31 | 9.64 | $-0.37 | 0.00 |
| 2018-09-30 | 14.25 | $0.40 | 35.69 |
| 2018-06-30 | 12.00 | $0.58 | 20.70 |
| 2018-03-31 | 12.35 | $0.66 | 18.57 |
| 2017-12-31 | 14.55 | $0.68 | 21.49 |
| 2017-09-30 | 14.23 | $0.44 | 32.59 |
| 2017-06-30 | 12.76 | $0.43 | 29.82 |
| 2017-03-31 | 12.68 | $0.65 | 19.56 |
| 2016-12-31 | 10.21 | $0.78 | 13.14 |
| 2016-09-30 | 13.17 | $0.83 | 15.85 |
| 2016-06-30 | 12.70 | $0.88 | 14.42 |
| 2016-03-31 | 13.21 | $0.82 | 16.16 |
| 2015-12-31 | 15.38 | $0.78 | 19.77 |
| 2015-09-30 | 12.40 | $0.62 | 20.12 |
| 2015-06-30 | 13.68 | $0.50 | 27.21 |
| 2015-03-31 | 11.96 | $0.44 | 27.18 |
| 2014-12-31 | 12.77 | $0.20 | 62.97 |
| 2014-09-30 | 13.42 | $-0.05 | 0.00 |
| 2014-06-30 | 16.05 | $-0.10 | 0.00 |
| 2014-03-31 | 18.03 | $-0.28 | 0.00 |
| 2013-12-31 | 15.46 | $-0.20 | 0.00 |
| 2013-09-30 | 14.87 | $0.02 | 830.73 |
| 2013-06-30 | 12.94 | $0.11 | 118.82 |
| 2013-03-31 | 13.59 | $0.43 | 31.86 |
| 2012-12-31 | 9.42 | $0.56 | 16.91 |
| 2012-09-30 | 12.42 | $0.84 | 14.87 |
| 2012-06-30 | 10.93 | $0.88 | 12.49 |
| 2012-03-31 | 16.60 | $0.98 | 16.98 |
| 2011-12-31 | 18.94 | $0.96 | 19.70 |
| 2011-09-30 | 18.02 | $0.25 | 72.57 |
| 2011-06-30 | 19.42 | $0.09 | 219.19 |
| 2011-03-31 | 20.99 | $0.28 | 75.56 |
| 2010-12-31 | 19.27 | $-0.22 | 0.00 |
| 2010-09-30 | 18.47 | $0.36 | 51.56 |
| 2010-06-30 | 16.10 | $0.89 | 18.02 |
| 2010-05-31 | 18.81 | $0.26 | 71.52 |
| 2010-03-31 | 19.58 | $0.41 | 47.74 |
| 2010-02-28 | 17.89 | $0.34 | 52.52 |
| 2009-12-31 | 20.23 | 0 | 0.00 |
| 2009-11-30 | 19.20 | $0.17 | 112.02 |
| 2009-09-30 | 20.27 | $0.34 | 59.58 |
| 2009-08-31 | 14.85 | $-0.20 | 0.00 |
| 2009-05-31 | 12.91 | $-0.07 | 0.00 |
| 2009-02-28 | 8.70 | $-0.25 | 0.00 |
| 2008-11-30 | 7.70 | $-0.08 | 0.00 |
| 2008-09-30 | 6.61 | $0.10 | 65.06 |
| 2008-08-31 | 7.62 | $-0.01 | 0.00 |
| 2008-06-30 | 6.59 | $0.09 | 69.85 |
| 2008-05-31 | 6.60 | $0.04 | 164.71 |
| 2008-03-31 | 5.48 | $0.29 | 18.82 |
| 2008-02-29 | 5.67 | $0.15 | 39.10 |
| 2007-12-31 | 10.32 | $-0.09 | 0.00 |
| 2007-11-30 | 9.40 | $-0.06 | 0.00 |
| 2007-09-30 | 14.36 | $-0.12 | 0.00 |
| 2007-06-30 | 13.54 | $0.04 | 341.04 |
| 2007-05-31 | 13.05 | $0.36 | 36.61 |
| 2007-03-31 | 14.25 | $0.17 | 83.11 |
| 2006-12-31 | 14.34 | $0.24 | 60.59 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.490B | $0.000B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Enovis (ENOV) | United States | $1.405B | 7.40 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |